Transthyretin as a Novel Biomarker for Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients
Background: Hepatocellular carcinoma [HCC] is one of the leading causes of cancer-related deaths worldwide. A major problem with HCC surveillance is the lack of reliable biomarkers. Serum transthyretin [TTR] may be a sensitive marker for the diagnosis of patients with liver cell damage, liver cirrho...
Main Authors: | Magda Ibrahim, Fathiya El-Raey, Naglaa Fathy, Kadrey El-Bakrey |
---|---|
Format: | Article |
Language: | English |
Published: |
Egyptian knowledge bank
2020-04-01
|
Series: | International Journal of Medical Arts |
Subjects: | |
Online Access: | https://ijma.journals.ekb.eg/article_82380_37df342f1483d981733ec70d834c8af1.pdf |
Similar Items
-
Transcatheter hepatic arterial chemoembolization in cirrhotic patients with hepatocellular carcinoma before liver transplantation: the prognostic value of alpha-fetoprotein concentrations
by: D. A. Granov, et al.
Published: (2021-01-01) -
Simple Clinical Metrics Enhance AFP to Effectively Identify Cirrhotic Patients With Complicating Hepatocellular Carcinoma at Various AFP Levels
by: Xi Zhang, et al.
Published: (2020-01-01) -
In whom, how and how often is surveillance for hepatocellular carcinoma cost-effective?
by: Ana Lilia Ruelas-Villavicencio, et al.
Published: (2004-10-01) -
Subtle Hepatocellular Carcinoma: A Persisting Role for Alpha-Fetoprotein Monitoring in High-Risk Patients with Cirrhosis
by: Barry Schlansky, et al.
Published: (2011-10-01) -
Status of, and strategies for improving, adherence to HCC screening and surveillance
by: Francica G, et al.
Published: (2019-07-01)